Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | +1.10% |
|
+0.73% | +10.40% |
Jun. 03 | Oncocyte Corporation Announces Promising Results in A Phase 2 Clinical Trial | CI |
May. 30 | Oncocyte Corporation Announces Favorable Oncocyte Vitgraft Kidney Study Results | CI |
Financials (USD)
Sales 2024 * | 1.51M | Sales 2025 * | 4.83M | Capitalization | 36.89M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -20M | EV / Sales 2024 * | 24.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.64 x |
P/E ratio 2024 * |
-1
x | P/E ratio 2025 * |
-1.62
x | Employees | 45 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.2% |
Latest transcript on OncoCyte Corporation
1 day | +1.10% | ||
1 week | +0.73% | ||
Current month | +0.73% | ||
1 month | -4.83% | ||
3 months | -6.44% | ||
6 months | -5.15% | ||
Current year | +10.40% |
![Extreme 2.64](/images/extremecours_fleche.png)
![Extreme 2.5566](/images/extremecours_fleche.png)
![Extreme 2.285](/images/extremecours_fleche.png)
![Extreme 2.08](/images/extremecours_fleche.png)
![Extreme 2.08](/images/extremecours_fleche.png)
![Extreme 2.08](/images/extremecours_fleche.png)
![Extreme 2.08](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Joshua Riggs
CEO | Chief Executive Officer | 42 | 20-07-31 |
James Liu
DFI | Director of Finance/CFO | 29 | 21-06-30 |
Yuh-Min Chiang
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Last
BRD | Director/Board Member | 64 | 15-12-22 |
Louis Silverman
BRD | Director/Board Member | 65 | 22-11-29 |
Andy Arno
CHM | Chairman | 64 | 15-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 2.76 | +1.10% | 23,541 |
24-06-13 | 2.73 | -0.73% | 13,599 |
24-06-12 | 2.75 | +0.36% | 11,950 |
24-06-11 | 2.74 | +1.86% | 9,570 |
24-06-10 | 2.69 | -1.82% | 14,872 |
Delayed Quote Nasdaq, June 14, 2024 at 03:29 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.40% | 36.89M | |
-43.39% | 7.73B | |
+11.68% | 3.7B | |
-21.21% | 1.99B | |
-23.77% | 1.6B | |
+14.81% | 999M | |
+18.25% | 739M | |
-10.04% | 685M | |
-36.12% | 461M | |
-4.47% | 279M |
- Stock Market
- Equities
- OCX Stock